Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
GANX —
GAIN THERAPEUTICS INC
CUSIP: 36269B105 · Held by 3 superinvestors · Combined value: $2,226,736
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | David Einhorn | 0.1% | $1,921,158 | 588,410 | - | - |
| 2 | Ken Griffin | 0.0% | $249,550 | 77,500 | REDUCE | -306,358 |
| 3 | Jim Simons | 0.0% | $56,028 | 17,400 | REDUCE | -108,700 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | REDUCE | -108,700 | -86.2% |
| Ken Griffin | REDUCE | -306,358 | -79.8% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +32,100 | +34.1% |
| Ken Griffin | ADD | +222,042 | +137.2% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| David Einhorn | ADD | +41,850 | +7.7% |
Who Owns GANX? Superinvestor Holdings
GAIN THERAPEUTICS INC is held by 3 tracked superinvestors, with a combined position value of $2 million . The largest positions are held by David Einhorn (0.1% of portfolio), Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter2 reduced or exited.